The Extractables and Leachables Safety Information Exchange (ELSIE) consortium is the preeminent international organization recognized for its expert knowledge of E&Ls in the biopharmaceutical and medical device industry. Through the development of a comprehensive ELSIE Knowledge Base, proactive networking, and regulatory engagement, ELSIE positively impacts E&L science and saves members resources. ELSIE creates value for its membership by: Collecting, reviewing and compiling data on E&Ls to facilitate risk assessments and material selection. Improving the probability of regulatory success by advancing understanding of the impact of E&Ls on product quality and process performance. Providing its members the opportunity to share and leverage experiences, insights, practices, and concerns. Supporting and publishing original research and collectively and actively representing its membership in the global scientific and regulatory communities. info@elsiedata.org

Driven by our global regulatory expertise and in-depth therapeutic knowledge, NAMSA is a medical CRO offering only the most proven solutions to move your medical device through the development lifecycle as efficiently and cost-effectively as possible. As a medical contract research organization, we are dedicated to helping you achieve accelerated, successful development and commercialization outcomes. NAMSA’s offerings include medical device testing; regulatory, reimbursement and quality consulting; and clinical research services.

ONdrugDelivery provides readers throughout global pharma/biopharma with the latest, most pertinent industry information and intelligence about the drug delivery-related ideas, technologies, services and products the sector is developing. Established in 2004, and trusted throughout the industry for its high quality contributions from leading drug delivery experts, ONdrugDelivery is a must for pharma / biotech industry professionals who need to know what’s going on in drug delivery. Subscribe online today to the print or free digital edition: https://ondrugdelivery.com/subscribe/